PharmacyCodes



Pyrazinoic acid amide en es it fr

Pyrazinoic acid amide Brand names, Pyrazinoic acid amide Analogs

Pyrazinoic acid amide Brand Names Mixture

  • No information avaliable

Pyrazinoic acid amide Chemical_Formula

C43H51N3O11

Pyrazinoic acid amide RX_link

http://www.rxlist.com/cgi/generic/xifaxan.htm

Pyrazinoic acid amide fda sheet

Pyrazinoic_acid_amide FDA

Pyrazinoic acid amide msds (material safety sheet)

Pyrazinoic_acid_amide MSDS

Pyrazinoic acid amide Synthesis Reference

No information avaliable

Pyrazinoic acid amide Molecular Weight

785.879 g/mol

Pyrazinoic acid amide Melting Point

No information avaliable

Pyrazinoic acid amide H2O Solubility

No information avaliable

Pyrazinoic acid amide State

No information avaliable

Pyrazinoic acid amide LogP

4.161

Pyrazinoic acid amide Dosage Forms

No information avaliable

Pyrazinoic acid amide Indication

For the treatment of patients (>=12 years of age) with travelers' diarrhea caused by noninvasive strains of Escherichia coli.

Pyrazinoic acid amide Pharmacology

Rifaximin is a structural analog of rifampin and non-systemic, gastrointestinal site-specific antibiotic. Rifaximin acts by inhibiting bacterial ribonucleic acid (RNA) synthesis. While an increase in pulmonary hydrogen excretion is evident in diverticular disease, the therapeutic effect of rifaximin does not appear to be due to a persistent correction of this alteration and the drug appears to cause no significant imbalance in the intestinal ecosystem.

Pyrazinoic acid amide Absorption

Low absorption in both the fasting state and when administered within 30 minutes of a high-fat breakfast.

Pyrazinoic acid amide side effects and Toxicity

LD50 > 2 g/kg (orally, in rats)

Pyrazinoic acid amide Patient Information

No information avaliable

Pyrazinoic acid amide Organisms Affected

Enteric bacteria and eubacteria